Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2) is a nuclear RNA-binding protein that participates in alternative mRNA splicing, associates with chromatin, and plays a regulatory role in DNA damage repair through modulation of topoisomerase II activity[1][3][6][7]. It is localized mainly in the nucleoplasm and is dynamically associated with chromatin depending on cellular conditions[3][5][6]. HNRNPUL2 interacts with regulators of DNA topology and is rapidly recruited to the nucleus and regions of DNA damage, where its expression correlates with resistance to DNA double-strand breakage and enhanced DNA repair capacity[1]. Although closely related proteins in the hnRNP family are implicated in neurodevelopmental and other disorders, there are no current drug therapies targeting HNRNPUL2, nor is it recognized as a therapeutic receptor, enzyme, or transporter[3][6][7]. Its precise function extends to the maintenance of genomic stability, and its biological roles likely interface at the crossroads of RNA processing and DNA integrity maintenance[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2).